ARCHIVES

Congress Approves More Favorable Terms for Office-Administered Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 31 | August 8, 1997

Download PDF Visit The Full Archive

Related Articles

Partial Responses To Zactima In Thyroid Cancer Trial

January 27, 2006

MSKCC Asked To Repay $638,371 To NIH

December 13, 1985

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

DOD Names Innovator Award Recipients.

April 26, 2002

In Brief: “Massive Reassessment” Of Centers Going On, Tim Talbot Believes; WHO Drops ICRB Service

December 9, 1977